"I went to the doctor twice and was told it was poor diet and working long hours, so I didn't think too much of it," he said.

Growth hormone was not associated with a lower risk for the composite liver outcome among patients with adult-onset craniopharyngioma.

Although craniopharyngioma is often considered a pediatric disease, up to half of cases are diagnosed in adulthood. These central nervous system tumors occur at a rate of 0.5-2 cases per million ...

Recent advances in molecular biology have introduced targeted therapies, such as BRAF and MEK inhibitors, which show potential benefits in craniopharyngioma patients, particularly in the PCP. For ACP, ...